RetiSpec and Gentex are partnering to develop a technology to detect Alzheimer’s disease — potentially years before symptom onset — using a non-invasive and cost-effective eye scan technique. The partnership between the two companies will expedite the development of the technology, with the goal of bringing it to market to advance patient care. “The Gentex-RetiSpec partnership reinforces our commitment to bring to market RetiSpec’s novel retinal imaging technology, a widely scalable and affordable way to accurately…
You must be logged in to read/download the full post.
The post RetiSpec and Gentex Developing Technology to Detect Early Alzheimer’s appeared first on BioNewsFeeds.